Physician profile
Michael A Brager
NPI 1164497194
$2,669.21
in general payments reported to CMS, 2019-2025
26 companies · $792 in 2025
The $792 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,078 · 2020: $252 · 2021: $205 · 2022: $188 · 2023: $93.61 · 2024: $60.34 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $615 · Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $615.37 |
| Food and Beverage | $330.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $615.37 | 2025 | |
| Smith+Nephew, INC. | $349.82 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $265.38 | 2019-2024 | Euflexxa |
| Bioventus LLC | $191.48 | 2019-2025 | Xcell, Gelsyn-3, Durolane |
| Abbott Laboratories | $164.55 | 2019-2022 | |
| Pinnacle, INC | $137.76 | 2019-2025 | |
| Trice Medical, INC. | $133.10 | 2019 | |
| Vericel Corporation | $112.33 | 2019-2023 | Maci |
| Horizon Therapeutics Plc | $110.67 | 2019-2021 | |
| Fidia Pharma USA INC. | $99.94 | 2019-2020 | |
| Depuy Synthes Sales INC. | $91.14 | 2019-2025 | Truespan Orthocord, Orthovisc, Peak |
| Orthogenrx INC. | $56.32 | 2019 | |
| Acumed LLC | $51.01 | 2019 | |
| Davol INC. | $42.80 | 2020 | |
| Ethicon US, LLC | $40.07 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $25.47 | 2019 | |
| Convatec INC. | $22.48 | 2022 | |
| Baxter Healthcare | $21.13 | 2020 | |
| Embody, INC. | $20.95 | 2022 | |
| Becton, Dickinson and Company | $19.62 | 2019 | |
| Amgen INC. | $18.55 | 2021 | |
| Sanofi-Aventis U.S. LLC | $18.51 | 2020 | |
| Ermi LLC | $17.73 | 2019 | |
| Biotissue Holdings INC. | $15.83 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.48 | 2022 | |
| Djo, LLC | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.